Musculoskeletal complication in kaposiform hemangioendothelioma without Kasabach-Merritt phenomenon: clinical characteristics and management

about

Musculoskeletal complication in kaposiform hemangioendothelioma without Kasabach-Merritt phenomenon: clinical characteristics and management

Item

http://www.wikidata.org/entity/Q58759095

description

im Januar 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Musculoskeletal complication i ...... characteristics and management

@en

Musculoskeletal complication i ...... characteristics and management

@nl

type

Item

label

Musculoskeletal complication i ...... characteristics and management

@en

Musculoskeletal complication i ...... characteristics and management

@nl

prefLabel

Musculoskeletal complication i ...... characteristics and management

@en

Musculoskeletal complication i ...... characteristics and management

@nl

P1476

Musculoskeletal complication i ...... characteristics and management

@en

P2093

Guoyan Lu

http://www.w3.org/2001/XMLSchema#string

Kaiying Yang

http://www.w3.org/2001/XMLSchema#string

Siyuan Chen

http://www.w3.org/2001/XMLSchema#string

Suhua Peng

http://www.w3.org/2001/XMLSchema#string

Xingtao Liu

http://www.w3.org/2001/XMLSchema#string

Yi Ji

http://www.w3.org/2001/XMLSchema#string

P2860

Residual lesions after Kasabach-Merritt phenomenon in 41 patients

Infants with Kasabach-Merritt syndrome do not have "true" hemangiomas

Rapamycin inhibits hepatic stellate cell proliferation in vitro and limits fibrogenesis in an in vivo model of liver fibrosis

Kaposiform hemangioendothelioma without Kasabach-Merritt phenomenon.

Primary kaposiform hemangioendothelioma of a long bone: two cases in unusual locations with long-term follow up.

Kaposiform hemangioendothelioma: atypical features and risks of Kasabach-Merritt phenomenon in 107 referrals

Long-term outcome of vincristine-aspirin-ticlopidine (VAT) therapy for vascular tumors associated with Kasabach-Merritt phenomenon.

Consensus-derived practice standards plan for complicated Kaposiform hemangioendothelioma.

Successful treatment of Kaposiform hemangioendothelioma with everolimus.

Recent advances in the pathobiology and management of Kasabach-Merritt phenomenon.

P304

3325-3331

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/CMAR.S171223

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30233248

http://www.w3.org/2001/XMLSchema#string

P932

6135070

http://www.w3.org/2001/XMLSchema#string